nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—CYP2C19—Sorafenib—thyroid cancer	0.115	0.284	CbGbCtD
Metoprolol—ABCB1—Sorafenib—thyroid cancer	0.0927	0.229	CbGbCtD
Metoprolol—CYP2D6—Sorafenib—thyroid cancer	0.0873	0.216	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—thyroid cancer	0.0562	0.139	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—thyroid cancer	0.053	0.131	CbGbCtD
Metoprolol—Mediastinal disorder—Sorafenib—thyroid cancer	0.00239	0.00401	CcSEcCtD
Metoprolol—Constipation—Vandetanib—thyroid cancer	0.00239	0.00401	CcSEcCtD
Metoprolol—Pain—Vandetanib—thyroid cancer	0.00239	0.00401	CcSEcCtD
Metoprolol—Arrhythmia—Sorafenib—thyroid cancer	0.00237	0.00398	CcSEcCtD
Metoprolol—Alopecia—Sorafenib—thyroid cancer	0.00235	0.00394	CcSEcCtD
Metoprolol—Mental disorder—Sorafenib—thyroid cancer	0.00233	0.0039	CcSEcCtD
Metoprolol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00229	0.00384	CcSEcCtD
Metoprolol—Dysgeusia—Sorafenib—thyroid cancer	0.00226	0.0038	CcSEcCtD
Metoprolol—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00222	0.00373	CcSEcCtD
Metoprolol—Muscle spasms—Sorafenib—thyroid cancer	0.00222	0.00373	CcSEcCtD
Metoprolol—Abdominal pain—Vandetanib—thyroid cancer	0.00221	0.00371	CcSEcCtD
Metoprolol—Body temperature increased—Vandetanib—thyroid cancer	0.00221	0.00371	CcSEcCtD
Metoprolol—Syncope—Sorafenib—thyroid cancer	0.00207	0.00348	CcSEcCtD
Metoprolol—Leukopenia—Sorafenib—thyroid cancer	0.00207	0.00347	CcSEcCtD
Metoprolol—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00206	0.00345	CcSEcCtD
Metoprolol—Loss of consciousness—Sorafenib—thyroid cancer	0.00203	0.00341	CcSEcCtD
Metoprolol—Atrioventricular block—Epirubicin—thyroid cancer	0.00201	0.00338	CcSEcCtD
Metoprolol—Asthenia—Vandetanib—thyroid cancer	0.00201	0.00337	CcSEcCtD
Metoprolol—Hypertension—Sorafenib—thyroid cancer	0.002	0.00335	CcSEcCtD
Metoprolol—Pruritus—Vandetanib—thyroid cancer	0.00198	0.00332	CcSEcCtD
Metoprolol—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00198	0.00332	CcSEcCtD
Metoprolol—Arthralgia—Sorafenib—thyroid cancer	0.00197	0.0033	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00195	0.00328	CcSEcCtD
Metoprolol—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00195	0.00328	CcSEcCtD
Metoprolol—Abnormal dreams—Epirubicin—thyroid cancer	0.00193	0.00324	CcSEcCtD
Metoprolol—Dry mouth—Sorafenib—thyroid cancer	0.00192	0.00323	CcSEcCtD
Metoprolol—Diarrhoea—Vandetanib—thyroid cancer	0.00191	0.00321	CcSEcCtD
Metoprolol—Atrioventricular block—Doxorubicin—thyroid cancer	0.00186	0.00313	CcSEcCtD
Metoprolol—Shock—Sorafenib—thyroid cancer	0.00186	0.00311	CcSEcCtD
Metoprolol—Nervous system disorder—Sorafenib—thyroid cancer	0.00185	0.0031	CcSEcCtD
Metoprolol—Dizziness—Vandetanib—thyroid cancer	0.00185	0.0031	CcSEcCtD
Metoprolol—Thrombocytopenia—Sorafenib—thyroid cancer	0.00185	0.0031	CcSEcCtD
Metoprolol—Skin disorder—Sorafenib—thyroid cancer	0.00183	0.00307	CcSEcCtD
Metoprolol—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00183	0.00307	CcSEcCtD
Metoprolol—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00181	0.00303	CcSEcCtD
Metoprolol—Dry eye—Epirubicin—thyroid cancer	0.0018	0.00303	CcSEcCtD
Metoprolol—Abnormal dreams—Doxorubicin—thyroid cancer	0.00179	0.003	CcSEcCtD
Metoprolol—Coma—Epirubicin—thyroid cancer	0.00179	0.003	CcSEcCtD
Metoprolol—Vomiting—Vandetanib—thyroid cancer	0.00178	0.00298	CcSEcCtD
Metoprolol—Rash—Vandetanib—thyroid cancer	0.00176	0.00296	CcSEcCtD
Metoprolol—Dermatitis—Vandetanib—thyroid cancer	0.00176	0.00296	CcSEcCtD
Metoprolol—Headache—Vandetanib—thyroid cancer	0.00175	0.00294	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00172	0.00288	CcSEcCtD
Metoprolol—Mental disability—Epirubicin—thyroid cancer	0.0017	0.00284	CcSEcCtD
Metoprolol—Dyspnoea—Sorafenib—thyroid cancer	0.00168	0.00282	CcSEcCtD
Metoprolol—Dry eye—Doxorubicin—thyroid cancer	0.00167	0.0028	CcSEcCtD
Metoprolol—Nausea—Vandetanib—thyroid cancer	0.00166	0.00279	CcSEcCtD
Metoprolol—Dyspepsia—Sorafenib—thyroid cancer	0.00166	0.00279	CcSEcCtD
Metoprolol—Coma—Doxorubicin—thyroid cancer	0.00165	0.00277	CcSEcCtD
Metoprolol—Diabetes mellitus—Epirubicin—thyroid cancer	0.00163	0.00274	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00163	0.00273	CcSEcCtD
Metoprolol—Fatigue—Sorafenib—thyroid cancer	0.00163	0.00273	CcSEcCtD
Metoprolol—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00162	0.00272	CcSEcCtD
Metoprolol—Photosensitivity—Epirubicin—thyroid cancer	0.00162	0.00271	CcSEcCtD
Metoprolol—Pain—Sorafenib—thyroid cancer	0.00161	0.00271	CcSEcCtD
Metoprolol—Constipation—Sorafenib—thyroid cancer	0.00161	0.00271	CcSEcCtD
Metoprolol—Mental disability—Doxorubicin—thyroid cancer	0.00157	0.00263	CcSEcCtD
Metoprolol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00156	0.00262	CcSEcCtD
Metoprolol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00154	0.00259	CcSEcCtD
Metoprolol—Hot flush—Epirubicin—thyroid cancer	0.00152	0.00254	CcSEcCtD
Metoprolol—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00151	0.00253	CcSEcCtD
Metoprolol—Menopausal symptoms—Epirubicin—thyroid cancer	0.0015	0.00252	CcSEcCtD
Metoprolol—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.0015	0.00252	CcSEcCtD
Metoprolol—Urticaria—Sorafenib—thyroid cancer	0.0015	0.00251	CcSEcCtD
Metoprolol—Photosensitivity—Doxorubicin—thyroid cancer	0.00149	0.00251	CcSEcCtD
Metoprolol—Body temperature increased—Sorafenib—thyroid cancer	0.00149	0.0025	CcSEcCtD
Metoprolol—Abdominal pain—Sorafenib—thyroid cancer	0.00149	0.0025	CcSEcCtD
Metoprolol—Hypoglycaemia—Epirubicin—thyroid cancer	0.00145	0.00244	CcSEcCtD
Metoprolol—Cardiac failure—Epirubicin—thyroid cancer	0.00145	0.00244	CcSEcCtD
Metoprolol—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00145	0.00243	CcSEcCtD
Metoprolol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00145	0.00243	CcSEcCtD
Metoprolol—Hot flush—Doxorubicin—thyroid cancer	0.0014	0.00235	CcSEcCtD
Metoprolol—Affect lability—Epirubicin—thyroid cancer	0.0014	0.00234	CcSEcCtD
Metoprolol—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00139	0.00233	CcSEcCtD
Metoprolol—Hypersensitivity—Sorafenib—thyroid cancer	0.00139	0.00233	CcSEcCtD
Metoprolol—Asthenia—Sorafenib—thyroid cancer	0.00135	0.00227	CcSEcCtD
Metoprolol—Cardiac arrest—Epirubicin—thyroid cancer	0.00135	0.00226	CcSEcCtD
Metoprolol—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00134	0.00226	CcSEcCtD
Metoprolol—Cardiac failure—Doxorubicin—thyroid cancer	0.00134	0.00226	CcSEcCtD
Metoprolol—Mood swings—Epirubicin—thyroid cancer	0.00134	0.00225	CcSEcCtD
Metoprolol—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00134	0.00225	CcSEcCtD
Metoprolol—Pruritus—Sorafenib—thyroid cancer	0.00133	0.00224	CcSEcCtD
Metoprolol—Liver function test abnormal—Epirubicin—thyroid cancer	0.00131	0.0022	CcSEcCtD
Metoprolol—Orthostatic hypotension—Epirubicin—thyroid cancer	0.0013	0.00217	CcSEcCtD
Metoprolol—Abdominal pain upper—Epirubicin—thyroid cancer	0.0013	0.00217	CcSEcCtD
Metoprolol—Affect lability—Doxorubicin—thyroid cancer	0.00129	0.00217	CcSEcCtD
Metoprolol—Diarrhoea—Sorafenib—thyroid cancer	0.00129	0.00217	CcSEcCtD
Metoprolol—Breast disorder—Epirubicin—thyroid cancer	0.00128	0.00215	CcSEcCtD
Metoprolol—Cardiac arrest—Doxorubicin—thyroid cancer	0.00125	0.00209	CcSEcCtD
Metoprolol—Dizziness—Sorafenib—thyroid cancer	0.00125	0.00209	CcSEcCtD
Metoprolol—Mood swings—Doxorubicin—thyroid cancer	0.00124	0.00209	CcSEcCtD
Metoprolol—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00121	0.00203	CcSEcCtD
Metoprolol—Vomiting—Sorafenib—thyroid cancer	0.0012	0.00201	CcSEcCtD
Metoprolol—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.0012	0.00201	CcSEcCtD
Metoprolol—Abdominal pain upper—Doxorubicin—thyroid cancer	0.0012	0.00201	CcSEcCtD
Metoprolol—Angina pectoris—Epirubicin—thyroid cancer	0.00119	0.002	CcSEcCtD
Metoprolol—Rash—Sorafenib—thyroid cancer	0.00119	0.002	CcSEcCtD
Metoprolol—Dermatitis—Sorafenib—thyroid cancer	0.00119	0.00199	CcSEcCtD
Metoprolol—Breast disorder—Doxorubicin—thyroid cancer	0.00119	0.00199	CcSEcCtD
Metoprolol—Headache—Sorafenib—thyroid cancer	0.00118	0.00198	CcSEcCtD
Metoprolol—Nausea—Sorafenib—thyroid cancer	0.00112	0.00188	CcSEcCtD
Metoprolol—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00112	0.00188	CcSEcCtD
Metoprolol—Weight increased—Epirubicin—thyroid cancer	0.00112	0.00187	CcSEcCtD
Metoprolol—Angina pectoris—Doxorubicin—thyroid cancer	0.00111	0.00185	CcSEcCtD
Metoprolol—Pneumonia—Epirubicin—thyroid cancer	0.0011	0.00184	CcSEcCtD
Metoprolol—Jaundice—Epirubicin—thyroid cancer	0.00107	0.00179	CcSEcCtD
Metoprolol—Conjunctivitis—Epirubicin—thyroid cancer	0.00106	0.00178	CcSEcCtD
Metoprolol—Sweating—Epirubicin—thyroid cancer	0.00105	0.00176	CcSEcCtD
Metoprolol—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00104	0.00174	CcSEcCtD
Metoprolol—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00103	0.00173	CcSEcCtD
Metoprolol—Weight increased—Doxorubicin—thyroid cancer	0.00103	0.00173	CcSEcCtD
Metoprolol—Agranulocytosis—Epirubicin—thyroid cancer	0.00102	0.00171	CcSEcCtD
Metoprolol—Pneumonia—Doxorubicin—thyroid cancer	0.00102	0.00171	CcSEcCtD
Metoprolol—Bradycardia—Epirubicin—thyroid cancer	0.000999	0.00168	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—thyroid cancer	0.000986	0.00165	CcSEcCtD
Metoprolol—Rhinitis—Epirubicin—thyroid cancer	0.000984	0.00165	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—thyroid cancer	0.000983	0.00165	CcSEcCtD
Metoprolol—Hepatitis—Epirubicin—thyroid cancer	0.000981	0.00165	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—thyroid cancer	0.00097	0.00163	CcSEcCtD
Metoprolol—Oedema peripheral—Epirubicin—thyroid cancer	0.000967	0.00162	CcSEcCtD
Metoprolol—Connective tissue disorder—Epirubicin—thyroid cancer	0.000964	0.00162	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000957	0.0016	CcSEcCtD
Metoprolol—Visual impairment—Epirubicin—thyroid cancer	0.000946	0.00159	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—thyroid cancer	0.000944	0.00158	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—thyroid cancer	0.000924	0.00155	CcSEcCtD
Metoprolol—Eye disorder—Epirubicin—thyroid cancer	0.000917	0.00154	CcSEcCtD
Metoprolol—Tinnitus—Epirubicin—thyroid cancer	0.000915	0.00154	CcSEcCtD
Metoprolol—Cardiac disorder—Epirubicin—thyroid cancer	0.000911	0.00153	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—thyroid cancer	0.00091	0.00153	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—thyroid cancer	0.000908	0.00152	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—thyroid cancer	0.000895	0.0015	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000892	0.0015	CcSEcCtD
Metoprolol—Angiopathy—Epirubicin—thyroid cancer	0.00089	0.00149	CcSEcCtD
Metoprolol—Immune system disorder—Epirubicin—thyroid cancer	0.000886	0.00149	CcSEcCtD
Metoprolol—Mediastinal disorder—Epirubicin—thyroid cancer	0.000884	0.00148	CcSEcCtD
Metoprolol—Arrhythmia—Epirubicin—thyroid cancer	0.000877	0.00147	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—thyroid cancer	0.000875	0.00147	CcSEcCtD
Metoprolol—Alopecia—Epirubicin—thyroid cancer	0.000867	0.00145	CcSEcCtD
Metoprolol—Mental disorder—Epirubicin—thyroid cancer	0.00086	0.00144	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—thyroid cancer	0.000849	0.00142	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—thyroid cancer	0.000847	0.00142	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—thyroid cancer	0.000843	0.00141	CcSEcCtD
Metoprolol—Flatulence—Epirubicin—thyroid cancer	0.000842	0.00141	CcSEcCtD
Metoprolol—Tension—Epirubicin—thyroid cancer	0.000838	0.00141	CcSEcCtD
Metoprolol—Dysgeusia—Epirubicin—thyroid cancer	0.000837	0.0014	CcSEcCtD
Metoprolol—Nervousness—Epirubicin—thyroid cancer	0.00083	0.00139	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—thyroid cancer	0.000824	0.00138	CcSEcCtD
Metoprolol—Muscle spasms—Epirubicin—thyroid cancer	0.000821	0.00138	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—thyroid cancer	0.00082	0.00138	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000818	0.00137	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—thyroid cancer	0.000811	0.00136	CcSEcCtD
Metoprolol—Vision blurred—Epirubicin—thyroid cancer	0.000805	0.00135	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—thyroid cancer	0.000802	0.00135	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—thyroid cancer	0.000796	0.00133	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—thyroid cancer	0.000779	0.00131	CcSEcCtD
Metoprolol—Tension—Doxorubicin—thyroid cancer	0.000776	0.0013	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—thyroid cancer	0.000774	0.0013	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—thyroid cancer	0.000768	0.00129	CcSEcCtD
Metoprolol—Vertigo—Epirubicin—thyroid cancer	0.000768	0.00129	CcSEcCtD
Metoprolol—Syncope—Epirubicin—thyroid cancer	0.000766	0.00129	CcSEcCtD
Metoprolol—Leukopenia—Epirubicin—thyroid cancer	0.000765	0.00128	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—thyroid cancer	0.00076	0.00127	CcSEcCtD
Metoprolol—Palpitations—Epirubicin—thyroid cancer	0.000755	0.00127	CcSEcCtD
Metoprolol—Loss of consciousness—Epirubicin—thyroid cancer	0.000751	0.00126	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—thyroid cancer	0.000745	0.00125	CcSEcCtD
Metoprolol—Hypertension—Epirubicin—thyroid cancer	0.000738	0.00124	CcSEcCtD
Metoprolol—Arthralgia—Epirubicin—thyroid cancer	0.000727	0.00122	CcSEcCtD
Metoprolol—Chest pain—Epirubicin—thyroid cancer	0.000727	0.00122	CcSEcCtD
Metoprolol—Anxiety—Epirubicin—thyroid cancer	0.000725	0.00122	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000722	0.00121	CcSEcCtD
Metoprolol—Dry mouth—Epirubicin—thyroid cancer	0.000711	0.00119	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—thyroid cancer	0.00071	0.00119	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—thyroid cancer	0.000709	0.00119	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—thyroid cancer	0.000708	0.00119	CcSEcCtD
Metoprolol—Confusional state—Epirubicin—thyroid cancer	0.000703	0.00118	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—thyroid cancer	0.000699	0.00117	CcSEcCtD
Metoprolol—Oedema—Epirubicin—thyroid cancer	0.000697	0.00117	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—thyroid cancer	0.000695	0.00117	CcSEcCtD
Metoprolol—Shock—Epirubicin—thyroid cancer	0.000686	0.00115	CcSEcCtD
Metoprolol—Nervous system disorder—Epirubicin—thyroid cancer	0.000684	0.00115	CcSEcCtD
Metoprolol—Thrombocytopenia—Epirubicin—thyroid cancer	0.000683	0.00115	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—thyroid cancer	0.000682	0.00114	CcSEcCtD
Metoprolol—Tachycardia—Epirubicin—thyroid cancer	0.00068	0.00114	CcSEcCtD
Metoprolol—Skin disorder—Epirubicin—thyroid cancer	0.000677	0.00114	CcSEcCtD
Metoprolol—Hyperhidrosis—Epirubicin—thyroid cancer	0.000674	0.00113	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—thyroid cancer	0.000673	0.00113	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—thyroid cancer	0.000673	0.00113	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—thyroid cancer	0.000671	0.00113	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000668	0.00112	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—thyroid cancer	0.000658	0.0011	CcSEcCtD
Metoprolol—Hypotension—Epirubicin—thyroid cancer	0.000651	0.00109	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—thyroid cancer	0.00065	0.00109	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—thyroid cancer	0.000645	0.00108	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000635	0.00107	CcSEcCtD
Metoprolol—Shock—Doxorubicin—thyroid cancer	0.000635	0.00106	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—thyroid cancer	0.000633	0.00106	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000632	0.00106	CcSEcCtD
Metoprolol—Insomnia—Epirubicin—thyroid cancer	0.000631	0.00106	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—thyroid cancer	0.00063	0.00106	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—thyroid cancer	0.000627	0.00105	CcSEcCtD
Metoprolol—Paraesthesia—Epirubicin—thyroid cancer	0.000626	0.00105	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000624	0.00105	CcSEcCtD
Metoprolol—Dyspnoea—Epirubicin—thyroid cancer	0.000622	0.00104	CcSEcCtD
Metoprolol—Somnolence—Epirubicin—thyroid cancer	0.00062	0.00104	CcSEcCtD
Metoprolol—Dyspepsia—Epirubicin—thyroid cancer	0.000614	0.00103	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—thyroid cancer	0.000603	0.00101	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000602	0.00101	CcSEcCtD
Metoprolol—Fatigue—Epirubicin—thyroid cancer	0.000601	0.00101	CcSEcCtD
Metoprolol—Pain—Epirubicin—thyroid cancer	0.000596	0.001	CcSEcCtD
Metoprolol—Constipation—Epirubicin—thyroid cancer	0.000596	0.001	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000588	0.000986	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—thyroid cancer	0.000583	0.000979	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—thyroid cancer	0.000579	0.000972	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—thyroid cancer	0.000575	0.000965	CcSEcCtD
Metoprolol—Feeling abnormal—Epirubicin—thyroid cancer	0.000575	0.000964	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—thyroid cancer	0.000574	0.000962	CcSEcCtD
Metoprolol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00057	0.000956	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—thyroid cancer	0.000568	0.000953	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000557	0.000934	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—thyroid cancer	0.000556	0.000933	CcSEcCtD
Metoprolol—Urticaria—Epirubicin—thyroid cancer	0.000554	0.000929	CcSEcCtD
Metoprolol—Pain—Doxorubicin—thyroid cancer	0.000552	0.000926	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—thyroid cancer	0.000552	0.000926	CcSEcCtD
Metoprolol—Abdominal pain—Epirubicin—thyroid cancer	0.000551	0.000925	CcSEcCtD
Metoprolol—Body temperature increased—Epirubicin—thyroid cancer	0.000551	0.000925	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000532	0.000892	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000528	0.000885	CcSEcCtD
Metoprolol—Hypersensitivity—Epirubicin—thyroid cancer	0.000514	0.000862	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—thyroid cancer	0.000512	0.00086	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—thyroid cancer	0.00051	0.000856	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—thyroid cancer	0.00051	0.000856	CcSEcCtD
Metoprolol—Asthenia—Epirubicin—thyroid cancer	0.0005	0.000839	CcSEcCtD
Metoprolol—Pruritus—Epirubicin—thyroid cancer	0.000493	0.000828	CcSEcCtD
Metoprolol—Diarrhoea—Epirubicin—thyroid cancer	0.000477	0.0008	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—thyroid cancer	0.000475	0.000797	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—thyroid cancer	0.000463	0.000777	CcSEcCtD
Metoprolol—Dizziness—Epirubicin—thyroid cancer	0.000461	0.000773	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—thyroid cancer	0.000456	0.000766	CcSEcCtD
Metoprolol—Vomiting—Epirubicin—thyroid cancer	0.000443	0.000744	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—thyroid cancer	0.000441	0.000741	CcSEcCtD
Metoprolol—Rash—Epirubicin—thyroid cancer	0.00044	0.000738	CcSEcCtD
Metoprolol—Dermatitis—Epirubicin—thyroid cancer	0.000439	0.000737	CcSEcCtD
Metoprolol—Headache—Epirubicin—thyroid cancer	0.000437	0.000733	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—thyroid cancer	0.000427	0.000716	CcSEcCtD
Metoprolol—Nausea—Epirubicin—thyroid cancer	0.000414	0.000695	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—thyroid cancer	0.00041	0.000688	CcSEcCtD
Metoprolol—Rash—Doxorubicin—thyroid cancer	0.000407	0.000682	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—thyroid cancer	0.000406	0.000682	CcSEcCtD
Metoprolol—Headache—Doxorubicin—thyroid cancer	0.000404	0.000678	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—thyroid cancer	0.000383	0.000643	CcSEcCtD
